Literature DB >> 8172263

Color contrast sensitivity and pattern electroretinographic findings after diode and argon laser photocoagulation in diabetic retinopathy.

M R Ulbig1, G B Arden, A M Hamilton.   

Abstract

The retinal depth at which photocoagulation is maximal varies with wavelength. We compared visual function of eyes undergoing photocoagulation by the near-infrared diode laser to the argon green laser. We treated 14 patients with diabetic retinopathy requiring bilateral panretinal photocoagulation with the diode laser on the right eye and the argon system on the left eye. Before and after treatment visual acuity, central and peripheral color contrast sensitivity, and pattern electroretinograms were recorded. No difference was noted in the clinical response or visual acuity outcome, but a tendency was observed for less decline in color contrast sensitivity and pattern electroretinogram recordings after diode laser photocoagulation. Although P values (.05 to .5) did not reach significance, a mean of 8.4 of 14 patients per test had better test results after diode laser treatment. Diode laser photocoagulation seems to be a viable alternative to argon laser treatment and may be a more gentle mode of treatment.

Entities:  

Mesh:

Year:  1994        PMID: 8172263     DOI: 10.1016/s0002-9394(14)70063-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  Selective retina therapy (SRT) for clinically significant diabetic macular edema.

Authors:  Johann Roider; Shiao Hui Melissa Liew; Carsten Klatt; Hanno Elsner; Erk Poerksen; Jost Hillenkamp; Ralf Brinkmann; Reginald Birngruber
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09       Impact factor: 3.117

2.  Clinical comparison of semiconductor diode versus neodymium: YAG non-contact cyclo photocoagulation.

Authors:  M W Ulbig; D A McHugh; A I McNaught; A M Hamilton
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

3.  Morphologic changes in the retina after selective retina therapy.

Authors:  Ji Ho Yang; Seung-Young Yu; Tae Gi Kim; Eung Suk Kim; Hyung Woo Kwak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-18       Impact factor: 3.117

4.  A new colour vision arrangement test to detect functional changes in diabetic macular oedema.

Authors:  N Maár; M Tittl; M Stur; B Zajic; A Reitner
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

5.  Colour vision testing as an aid to diagnosis and management of age related maculopathy.

Authors:  G B Arden; J E Wolf
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

6.  Diode laser photocoagulation for diabetic macular oedema.

Authors:  M W Ulbig; D A McHugh; A M Hamilton
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

7.  Comparison of colour contrast sensitivity in eyes at high risk of neovascular age-related macular degeneration with and without subsequent choroidal neovascular membrane development.

Authors:  Antonio Calcagni; Olivia Howells; Hannah Bartlett; Alastair K O Denniston; Jonathan M Gibson; Christopher R Hogg; Timothy D Matthews; Frank Eperjesi
Journal:  Eye (Lond)       Date:  2022-01-20       Impact factor: 4.456

8.  Quantitative computerized color vision testing in diabetic retinopathy: A possible screening tool?

Authors:  Rashid Al Saeidi; Marcus Kernt; Thomas C Kreutzer; Guenther Rudolph; Aljoscha S Neubauer; Christos Haritoglou
Journal:  Oman J Ophthalmol       Date:  2013-09

Review 9.  Different lasers and techniques for proliferative diabetic retinopathy.

Authors:  Tanya Moutray; Jennifer R Evans; Noemi Lois; David J Armstrong; Tunde Peto; Augusto Azuara-Blanco
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

10.  The ChromaTest, a digital color contrast sensitivity analyzer, for diabetic maculopathy: a pilot study.

Authors:  Roger Wong; Jaheed Khan; Temi Adewoyin; Sobha Sivaprasad; Geoffrey B Arden; Victor Chong
Journal:  BMC Ophthalmol       Date:  2008-08-17       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.